Interchange Capital Partners
TMO icon

Interchange Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Interchange Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$507K Buy
750
+12
+2% +$7.13K 0.08% 205
2026
Q2 		$370K Sell
738
-451
-38% -$217K 0.07% 249
2026
Q1 		$592K Buy
1,189
+119
+11% +$64.6K 0.19% 117
2025
Q4 		$620K Sell
1,070
-8
-0.7% -$4.52K 0.12% 163
2025
Q3 		$524K Buy
1,078
+94
+10% +$43.8K 0.1% 173
2025
Q2 		$399K Sell
984
-177
-15% -$74K 0.09% 175
2025
Q1 		$578K Buy
1,161
+9
+0.8% +$4.87K 0.16% 122
2024
Q4 		$603K Sell
1,152
-393
-25% -$216K 0.22% 115
2024
Q3 		$957K Sell
1,545
-26
-2% -$15.4K 0.34% 78
2024
Q2 		$869K Buy
1,571
+835
+113% +$478K 0.32% 83
2024
Q1 		$431K Buy
736
+21
+3% +$11.8K 0.29% 84
2023
Q4 		$380K Sell
715
-108
-13% -$52.3K 0.29% 87
2023
Q3 		$417K Buy
823
+144
+21% +$76.7K 0.33% 77
2023
Q2 		$355K Sell
679
-404
-37% -$218K 0.27% 93
2023
Q1 		$627K Buy
1,083
+636
+142% +$358K 0.34% 73
2022
Q4 		$246K Buy
447
+1
+0.2% +$530 0.25% 96
2022
Q3 		$226K Sell
446
-35
-7% -$19.6K 0.25% 126
2022
Q2 		$261K Sell
481
-9
-2% -$4.95K 0.29% 106
2022
Q1 		$289K Buy
+490
New +$281K 0.3% 111
2021
Q4 		– Sell
-756
Closed -$431K – 191
2021
Q3 		$431K Sell
756
-2
-0.3% -$1.1K 0.72% 51
2021
Q2 		$382K Sell
758
-72
-9% -$34K 0.59% 62
2021
Q1 		$393K Sell
830
-31
-4% -$14.8K 0.21% 146
2020
Q4 		$401K Buy
+861
New +$404K 0.22% 126

Other funds holding TMO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Interchange Capital Partners's TMO Position: Q3 2026 in Review

Interchange Capital Partners increased its Thermo Fisher Scientific (TMO) stake by 1.6% in Q3 2026, buying an estimated $7.13K and bringing the position to 750 shares worth $507K. The position accounts for 0.08% of the portfolio, ranked #205.

Interchange Capital Partners first reported a position in TMO in Q4 2020 and has held it in 23 quarters since. The position peaked at $957K in Q3 2024. 2,340 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Interchange Capital Partners held 750 shares of Thermo Fisher Scientific worth $507K as of Q3 2026.
  • Interchange Capital Partners bought 12 Thermo Fisher Scientific shares in Q3 2026, an estimated $7.13K.
  • Thermo Fisher Scientific made up 0.08% of Interchange Capital Partners's portfolio in Q3 2026, its #205 holding.
  • Interchange Capital Partners first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 23 quarters since.
  • Interchange Capital Partners's Thermo Fisher Scientific position peaked at $957K in Q3 2024.
  • 2,340 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Interchange Capital Partners's 13F filing for Q3 2026, filed 28 Oct 2026.